Combination of convalescent plasma therapy and repurposed drugs to treat severe COVID-19 patient with multimorbidity.

Das, SK; Ranabhat, K; Bhattarai, SORCID logo; Karki, KB; Gyanwali, P; Paneru, HR; Nepal, B; Dumre, SP; Acharya, SP and (2021) Combination of convalescent plasma therapy and repurposed drugs to treat severe COVID-19 patient with multimorbidity. Clinical case reports, 9 (4). pp. 2132-2137. ISSN 2050-0904 DOI: 10.1002/ccr3.3964
Copy

Combination of convalescent plasma therapy and repurposed drugs such as dexamethasone and remdesivir could be beneficial for severe COVID-19 patients with obesity and chronic diseases such as diabetes and hypertension.
Item Type Article
Elements ID 195278
Official URL http://dx.doi.org/10.1002/ccr3.3964
Date Deposited 12 Oct 2022 15:32

Explore Further

picture_as_pdf
Combination of convalescent plasma therapy and repurposed drugs to treat severe.pdf
subject
Published Version
Available under Creative Commons: Attribution 4.0
View Download

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL Data Cite XML EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads